NASDAQ OMX

hemCheck approved for trading on Nasdaq First North - Regulatory

Dela

hemCheck approved for trading on Nasdaq First North - Regulatory

This Press Release should not be released or distributed, directly or indirectly, within USA, Canada, Japan, Australia, Hong Kong, Switzerland, Singapore, South Africa, New Zealand or any other jurisdictions where distribution would be subject to legal restrictions.

Nasdaq First North has approved hemCheck Sweden AB's (publ) ('hemCheck' or the 'Company') application for listing of the Company's shares, and subscription option rights of series TO 1, for admission for trading on Nasdaq First North. The first trading day will be 15 March 2017. The ticker symbol for the Company's shares on First North is HEMC, the ticker symbol for the subscription option rights is HEMC TO 1.

hemCheck develops and commercializes a unique product concept (Helge(TM) and READY(TM)) that detects hemolysis in blood samples at the point of care. Nasdaq Stockholm AB has approved hemCheck's application for the Company's shares and subscription option rights (series TO 1) to begin trading on Nasdaq First North. The first day of trading will be March 15, 2017.

hemCheck CEO Annelie Brolinson:
"We're delighted interest in our share issue has been so great. We look forward to begin trading on 15 March. The whole team at hemCheck will continue to keep working hard to meet all our shareholders' expectations. As previously announced we will now finalize our product concept, consisting of Helge(TM) and READY(TM), for CE marking. We can then go full speed ahead with the market launch of our concept, starting in Sweden."

Background
In February hemCheck announced that the company had received over 1900 new shareholders through a new issue of units. Each unit consisted of one share and one subscription option rights of series TO 1. With subscription option rights issued free of charge the subscription price per unit amounted to SEK 6 per share. The issue volume of 28.2 million initially signed to approximately 59 MSEK, a subscription rate equivalent to approx. 209%. As the rights issue was oversubscribed, the Board decided to make full use of an over-allotted issue. The company thus initially raised approx. 30 MSEK prior to listing, and if all share issue costs and / or all outstanding subscription option rights will be used before Q1 2018, the Company will receive an additional 30 MSEK before issue costs.

The ticker symbol for the Company's shares on First North is HEMC, the ticker symbol for subscription option rights is HEMC TO 1.

Conditions for subscription option rights
Possession of a series TO 1 subscription option rights entitles the owner to subscribe for one of the new shares at a price of SEK 6 for a period from 29 January 2018, up to and including 9 February 2018.

Full details on how warrants will be used for subscription of shares in hemCheck will be made available on the Company's website,www.hemcheck.com, and Aktieinvest's website www.aktieinvest.se from 29 January 2018. Full terms and conditions for the warrants of series TO 1 will be detailed in the section Full terms and conditions for the warrants of series TO 1 in the prospectus being prepared for the new share issue, which is available on the Company website.

Advisors
Corpura AB is the financial advisor for the new share issue, and Fredersen Advokatbyrå AB is acting legal advisor. hemCheck's Certified Adviser on Nasdaq First North will be Corpura AB. Aktieinvest FK AB is acting as receiving agent in connection with the rights issue.

About hemCheck
hemCheck Sweden AB (publ) develops and commercializes a unique product concept (HELGE(TM) and READY(TM)) that detects hemolysis in blood samples at the point of care. Hemolysis, or the rupturing of red blood cells, is the most common reason for blood samples being unfit for analysis-which can lead to poorer healthcare, increased risk for patients and higher costs for clinics and society. By detecting hemolysis in blood tests directly, HELGE(TM) can contribute to improved care for patients throughout the world. hemCheck is headquartered in Karlstad, Sweden. hemCheck prepared a prospectus for the issue of new units before its resumption of trading on Nasdaq First North.

Contact
hemCheck Sweden AB (publ)
Annelie Brolinson, CEO
Tel: +46 70 288 0826
E-post: annelie.brolinson@hemcheck.com
Universitetsgatan 2
651 88 Karlstad
www.hemcheck.com

Important information
The information in this press release may not be published, reproduced or distributed in or into the United States, Canada, Japan, Australia, Hong Kong, Switzerland, Singapore, South Africa or New Zealand or any other country or other jurisdiction where such action is not permitted, or where such action is subject to legal restrictions or would require additional registration or other measures than those required by Swedish law. Actions in violation of this instruction may constitute a violation of applicable securities laws.

No interim units or units have been registered and will not be registered under the United States Securities Act of 1933 (the 'Securities Act') and may not be offered, subscribed to, sold or transferred, directly or indirectly, within the United States, except with the written approval from hemCheck and pursuant to an applicable exemption from the registration requirements of the Securities Act and in compliance with the securities laws of the relevant state or other jurisdiction of the United states.

This is information which hemCheck is required to disclose according to EU Market Abuse Regulation law. The information was provided by the above contact person's auspices, for publication on 13 March 2017, 1725.




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Hemcheck Sweden AB via Globenewswire

Om

NASDAQ OMX
NASDAQ OMX



Följ NASDAQ OMX

Skriv in din e-postadress så får du ett mejl när vi har något nytt att berätta.

Senaste pressmeddelandena från NASDAQ OMX

NRT Technology Completes Acquisition of VisuaLimits, One of the Fastest Growing Gaming Supplier Companies in the US26.9.2017 16:00Pressmeddelande

Acquisition of VisuaLimits Strengthens NRT's Ability to Connect the Guest Experience(TM) Across the Entire Casino Resort LAS VEGAS, Sept. 26, 2017 (GLOBE NEWSWIRE) -- NRT Technologies, Inc.,  a wholly-owned subsidiary of NRT Technology Corp. (together, "NRT") today announced the successful completion of its acquisition of VisuaLimits, LLC ("VL").   On September 20 2017, NRT and Sightline Payments announced an agreement to merge, with the combined entity to be called NRT Sightline (the "Transaction").  Following close of the Transaction, which remains subject to gaming regulatory approvals, Sightline's CEO and Founder, Kirk Sanford, will assume the role of CEO of NRT Sightline. NRT's current Founder, President and CEO, John Dominelli, will become Chairman of NRT Sightline and will remain active in leading the overall company strategy with a keen focus on driving the technology roadmap. The acquisition of VL complements N

Datameer Unveils New Visual Paradigm for Interactive Exploration of Data at Scale26.9.2017 15:02Pressmeddelande

Datameer extends its big data platform to add interactive functionality that enables self-service exploration of entire big data sets in seconds SAN FRANCISCO and NEW YORK, Sept. 26, 2017 (GLOBE NEWSWIRE) -- Datameer today unveiled an industry-first solution for instant, interactive visual exploration of entire datasets of any size. Being shown publicly for the first time at Strata Data Conference New York 2017, the new functionality will completely change the way analysts can work with big data directly within their data lake. Built on patent-pending dynamic indexing technology, Visual Explorer extends Datameer's core big data platform beyond integration, preparation and governed democratization of big data for analyses, to now add unconstrained interactive visual exploration of extremely large datasets. For the first time, data engineers and business analysts can use the same familiar spreadsheet-like interface to work with their data and with the click of a button, ins

IPsoft Launches Amelia Healthcare Practice to Transform the Healthcare Workforce and Patient Experience with Cognitive AI26.9.2017 14:00Pressmeddelande

NEW YORK, Sept. 26, 2017 (GLOBE NEWSWIRE) -- IPsoft, the leading digital labor company, is to launch a vertically focused portfolio of solutions for the healthcare industry based on its AI platform, Amelia. A series of Amelia Health Agent offerings are under development in a program of co-collaboration with healthcare providers, health systems, health insurers and life sciences organizations. The first releases will target high volume processes and interactions that will deliver tangible improvements for providers, insurers, carers and patients.  A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/04fe91f2-5d18-475f-b43e-7d1183aaba1b A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/4758c05a-915d-4278-8f55-6ed323f7649f A video accompanying this announcement is available at  http://www.globenewswire.com/NewsRoom/AttachmentNg/1be90122-0c

Percona Delivers MyRocks Storage Engine for MySQL26.9.2017 09:54Pressmeddelande

First Experimental Release of MyRocks with Percona Server for MySQL Enables Greater Performance at Lower Cost for High-Volume, Write-Intensive Workloads DUBLIN, Ireland, Sept. 26, 2017 (GLOBE NEWSWIRE) -- PERCONA LIVE OPEN SOURCE DATABASE CONFERENCE EUROPE - Percona, the company that delivers enterprise-class MySQL®, MongoDB® and other open source database solutions and services, today announced an experimental full release of Percona Server for MySQL 5.7 that includes the MyRocks storage engine. The powerful combination of Percona Server for MySQL and MyRocks will enable database administrators to achieve more throughput for high-volume, write-intensive workloads. Optimized for modern hardware, the product requires less storage space and reduces maintenance costs, providing increased ROI for on-premises and cloud-based applications. MyRocks, which integrates RocksDB as a MySQL storage engine, is optimized for modern hardware. When testing

Percona Monitoring and Management Adds New Capabilities for Improving MongoDB and MyRocks Performance26.9.2017 09:02Pressmeddelande

Free, Open Source Tool Monitors Performance and Provides Actionable Insights for MySQL and MongoDB Variants DUBLIN, Ireland, Sept. 26, 2017 (GLOBE NEWSWIRE) -- PERCONA LIVE OPEN SOURCE DATABASE CONFERENCE EUROPE - Percona, the company that delivers enterprise-class MySQL®, MongoDB® and other open source database solutions and services, today announced the release of Percona Monitoring and Management 1.3 (PMM), a significant update to the free and open-source platform for managing and monitoring MySQL®, MariaDB® and MongoDB® performance. This updated version adds new capabilities for improving the performance of MongoDB deployments and the MyRocks storage engine for MySQL. Percona Monitoring and Management provides point-in-time visibility and historical trending of database performance that enables DBAs and application developers to optimize the performance of their databases. Percona Monitoring and Management now includes: Query

Constellation Brands Plans Commercial Paper Program25.9.2017 22:30Pressmeddelande

VICTOR, N.Y., Sept. 25, 2017 (GLOBE NEWSWIRE) -- Constellation Brands, Inc. (NYSE:STZ) (NYSE:STZ.B) announced today that it plans to launch a commercial paper program pursuant to which it will offer and sell unsecured, unsubordinated notes, on a private placement basis, in reliance on an exemption from registration under the Securities Act of 1933, as amended (the "Securities Act"). The notes will not be redeemable prior to maturity or subject to voluntary prepayment. The proceeds of the notes will be used for general corporate purposes. The notes to be offered have not been and will not be registered under the Securities Act and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements. This news release shall not constitute an offer to sell or the solicitation of an offer to buy the company's notes under the commercial paper program. About Constellation Brands Const

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum